| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.9 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |